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ABSTRACT 
Hepatitis B virus infection is a serious health problem worldwide, and more than 350 million 
people are chronic carriers, constituting a major global threat. Southeast Asia and the 
Western Pacific have the highest levels of endemicity in the world, with an estimated 
seroprevalence ranging between 2% and 31%. Mutations in the hepatitis B surface antigen 
(HBsAg) have been reported in many parts of the world but are most common in Asian 
infants; such mutants have several clinical effects, such as the development of hepatocellular 
carcinoma. Diagnostic failures by commercial assays have reduced the diagnostic 
effectiveness of HBsAg detection. For example the substitution of an amino acid in the major 
hydrophilic region of the S gene reduces the binding of hepatitis B surface antibodies leading 
to immune escape. The safety of blood transfusion may be compromised by current screening 
tests due to escape from being neutralised by antibodies induced by HBsAg mutants, and 
undetectable levels of viral surface protein. Data on the epidemiology of HBsAg mutation in 
Asia Pacific are scant; however, this manuscript has reviewed the available information on 
the epidemiology of HBsAg mutation in Asia Pacific. 
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